Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Gross Sales	$ 4,606,796	$ 5,173,878	$ 14,469,698	$ 15,365,953
Allowances	0	0	0	(440,152)
Total Net Sales	4,606,796	5,173,878	14,469,698	14,925,801
Cost of sales	1,775,709	1,770,364	5,278,638	5,384,061
Gross Profit	2,831,087	3,403,514	9,191,060	9,541,740
Operating expenses	3,735,773	3,785,542	10,667,834	12,540,595
Loss from operations	(904,686)	(382,028)	(1,476,774)	(2,998,855)
Decrease of contingent liability	0	0	0	74,580
Change in fair value of convertible notes	0	854,506	87,380	(591,494)
Interest expense (income)	9,414	(12,741)	28,460	(31,558)
Loss before provision for income taxes	(895,272)	459,737	(1,360,934)	(3,547,327)
Net Loss (income)	(895,272)	459,737	(1,360,934)	(3,547,327)
Preferred dividends	333,500	1,000,500	2,334,501	3,001,501
Net Loss attributable to cbdMD, Inc. common shareholders	$ (1,228,772)	$ (540,763)	$ (3,695,435)	$ (6,548,828)
Net Loss per share:
Basic and Diluted earnings per share (in dollars per share)	$ (0.21)	$ (8.93)	$ (1.56)	$ (16.39)
Weighted average number of shares Basic and Diluted: (in shares)	5,783,354	449,121	2,376,157	399,496